Invitae Corporation (NVTA) |
| 0.019 -0.011 (-35.59%) 02-14 15:59 |
| Open: | 0.0172 |
| High: | 0.024 |
| Low: | 0.016 |
| Volume: | 22,459,258 |
| Market Cap: | 5(M) |
| PE Ratio: | -0 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 2.34 |
| 52w Low: | 0.015 |
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Thu, 08 Aug 2024
Invitae completes asset sale to Labcorp amid bankruptcy - Investing.com
Wed, 24 Apr 2024
Invitae Enters into Agreement with Labcorp for Sale of Business - PR Newswire
Tue, 12 Mar 2024
Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification - Stock Titan
Tue, 13 Feb 2024
Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process - PR Newswire
Mon, 05 Feb 2024
Why Is Invitae (NVTA) Stock Down 75% Today? - InvestorPlace
Mon, 05 Feb 2024
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |